Skip to content

TIOGUANINE

DRUG8 trials

Sponsors

Karolinska University Hospital, Universitaetsklinikum Muenster AöR, Universitaetsklinikum Schleswig-Holstein, Universita Degli Studi Di Milano Bicocca, Medical University Of Silesia Katowice Poland

Conditions

Acute Lymphoblastic LeukaemiaAcute lymphoblastic leukemiaLymphoblastic lymphomaOncologyacute lymphoblastic leukemia in children and adolescents

Phase 1

Phase 2

Phase 3

LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma
RecruitingCTIS2023-508101-24-00
Universitaetsklinikum Muenster AöRLymphoblastic lymphoma
Start: 2019-08-01Target: 544Updated: 2026-01-23
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Active, not recruitingCTIS2023-509856-32-00
Universitaetsklinikum Schleswig-Holsteinacute lymphoblastic leukemia in children and adolescents
Start: 2018-07-15Target: 4250Updated: 2025-08-19
International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones
Active, not recruitingCTIS2024-515499-12-00
Universita Degli Studi Di Milano BicoccaAcute lymphoblastic leukemia
Start: 2017-10-02Target: 306Updated: 2024-11-12
Collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia. A randomized phase III study conducted in agreement with the AIEOP-BFM study group.
Active, not recruitingCTIS2024-517253-27-00
Medical University Of Silesia Katowice PolandAcute lymphoblastic leukemia
Start: 2021-07-01Target: 874Updated: 2024-10-28
AIEOP-BFM ALL 2025 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Not yet recruitingCTIS2025-522190-11-01
Universitaetsklinikum Schleswig-Holstein AöRacute lymphoblastic leukemia in children and adolescents
Target: 2250Updated: 2026-07-09

Related Papers